Inventor · disambiguated record
Seamus Mulligan
Also filed as: MULLIGAN SEAMUS
15 granted patents·32 pending applications·1,517 citations·filing 1987–2024
96Inventor score
Files withALKERMES PHARMA IRELAND LTD25ELAN CORP PLC12CUNNINGHAM SEAN3ALKERNES PHARMA IRELAND LTD2ATHPHARMA LTD2
Top patents by PatentIndex Score
47 records- 0199US5616345AControlled absorption diltiazen formulation for once-daily administrationELAN CORP PLC·Filed 1994·Granted Apr 1, 1997·476 cites·12 claims
- 0294US4894240AControlled absorption diltiazem formulation for once-daily administrationELAN CORP PLC·Filed 1987·Granted Jan 16, 1990·164 cites·28 claims
- 0394US4891230ADiltiazem formulationELAN CORP PLC·Filed 1987·Granted Jan 2, 1990·80 cites·20 claims
- 0492US4973469ADrug delivery systemELAN CORP PLC·Filed 1989·Granted Nov 27, 1990·117 cites·12 claims
- 0591US2024156794A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2024·Application pending·0 cites
- 0690US5637320AControlled absorption naproxen formulation for once-daily administrationELAN CORP PLC·Filed 1994·Granted Jun 10, 1997·176 cites·17 claims
- 0790US5128142ASustained release drug delivery systemELAN CORP PLC·Filed 1989·Granted Jul 7, 1992·97 cites·12 claims
- 0890US2024058313A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 0988US2023293505A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2023·Application pending·0 cites
- 1087US4917899AControlled absorption diltiazem formulationELAN CORP PLC·Filed 1987·Granted Apr 17, 1990·85 cites·20 claims
- 1185US11786514B2Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2022·Granted Oct 17, 2023·0 cites·1 claims
- 1284US5015479ASustained release capsule or tablet formulation comprising a pharmaceutically acceptable dihydropyridineMULLIGAN SEAMUS·Filed 1988·Granted May 14, 1991·86 cites·14 claims
- 1384US2022265624A1Sustained release aminopyridine compositionALKERNES PHARMA IRELAND LTD·Filed 2022·Application pending·0 cites
- 1483US5002776AControlled absorption diltiazem formulationsELAN CORP PLC·Filed 1988·Granted Mar 26, 1991·69 cites·20 claims
- 1583US2022142999A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2022·Application pending·0 cites
- 1681US2022016094A1Sustained release aminopyridine compositionALKERNES PHARMA IRELAND LTD·Filed 2021·Application pending·0 cites
- 1781US2021308112A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2021·Application pending·0 cites
- 1878US2020093809A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 1978US2021059996A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2020·Application pending·0 cites
- 2077US2019381020A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 2176US5156842ALiquid suspension for oral administrationELAN CORP PLC·Filed 1991·Granted Oct 20, 1992·49 cites·10 claims
- 2276US2019240206A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 2376US2019231763A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 2476US2019134015A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2019·Application pending·0 cites
- 2576US2020338053A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2020·Application pending·0 cites
- 2675US5219621AMethods of treatment with diltiazem formulationsELAN CORP PLC·Filed 1992·Granted Jun 15, 1993·47 cites·4 claims
- 2775US2020230122A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2020·Application pending·0 cites
- 2875US2018369216A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2018·Application pending·0 cites
- 2974US2010272807A1Sustained release aminopyridine compositionCUNNINGHAM SEAN·Filed 2009·Application pending·0 cites
- 3074US2010272795A1Sustained release aminopyridine compositionCUNNINGHAM SEAN·Filed 2009·Application pending·0 cites
- 3174US2010272796A1Sustained release aminopyridine compositionCUNNINGHAM SEAN·Filed 2009·Application pending·0 cites
- 3274US2018256555A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2018·Application pending·0 cites
- 3373US2018125790A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2018·Application pending·0 cites
- 3472US2018055774A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 3571US2017258730A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 3670US2017165245A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2017·Application pending·0 cites
- 3770US2014018397A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2013·Application pending·0 cites
- 3869US5364620AControlled absorption diltiazem formulation for once daily administrationELAN CORP PLC·Filed 1992·Granted Nov 15, 1994·31 cites·6 claims
- 3969US2016324840A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2016·Application pending·0 cites
- 4068US2016175294A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2016·Application pending·0 cites
- 4167US2016081992A1Sustained Release Aminopyridine CompositionALKERMES PHARMA IRELAND LTD·Filed 2015·Application pending·0 cites
- 4267US2013045276A1Sustained release aminopyridine compositionALKERMES PHARMA IRELAND LTD·Filed 2012·Application pending·0 cites
- 4359US5336504ADiltiazem formulations and methods of treatmentELAN CORP PLC·Filed 1993·Granted Aug 9, 1994·22 cites·4 claims
- 4454US6641839B1Pharmaceutical formulations for preventing drug toleranceATHPHARMA LTD·Filed 1997·Granted Nov 4, 2003·18 cites·18 claims
- 4554US2007104788A1Once-daily administration of central nervous system drugsMULLIGAN SEAMUS·Filed 2006·Application pending·0 cites
- 4644US2004091534A1Pharmaceutical formulations for preventing drug toleranceATHPHARMA LTD·Filed 2003·Application pending·0 cites
- 4736US2011172210A1Method for titrating clozapineAZUR PHARMA LTD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Seamus Mulligan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →